These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9057164)
1. Serotonin 5-HT3 and 5-HT4 receptor antagonists. Gaster LM; King FD Med Res Rev; 1997 Mar; 17(2):163-214. PubMed ID: 9057164 [No Abstract] [Full Text] [Related]
2. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice. Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508 [TBL] [Abstract][Full Text] [Related]
3. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus. Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577 [TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors. Tonini M Neurogastroenterol Motil; 2005 Oct; 17(5):637-42. PubMed ID: 16185301 [No Abstract] [Full Text] [Related]
5. Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon. Kadowaki M; Wade PR; Gershon MD Am J Physiol; 1996 Nov; 271(5 Pt 1):G849-57. PubMed ID: 8944700 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives. Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033 [TBL] [Abstract][Full Text] [Related]
7. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor]. Lefebvre H Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490 [No Abstract] [Full Text] [Related]
8. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor. Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995 [TBL] [Abstract][Full Text] [Related]
9. Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. Jin JG; Foxx-Orenstein AE; Grider JR J Pharmacol Exp Ther; 1999 Jan; 288(1):93-7. PubMed ID: 9862758 [TBL] [Abstract][Full Text] [Related]
10. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats. Carley DW; Depoortere H; Radulovacki M Pharmacol Biochem Behav; 2001; 69(1-2):283-9. PubMed ID: 11420096 [TBL] [Abstract][Full Text] [Related]
11. The role of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the regulation of gut motility in the ferret. Nagakura Y; Kiso T; Ito H; Miyata K; Yamaguchi T Life Sci; 2000 May; 66(24):PL331-8. PubMed ID: 10864103 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives. Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243 [TBL] [Abstract][Full Text] [Related]
13. 5-HT4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats. Smith MI; Banner SE; Sanger GJ Neurosci Lett; 1999 Aug; 271(1):61-4. PubMed ID: 10471214 [TBL] [Abstract][Full Text] [Related]
14. Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors. Kato S; Matsuda N; Matsumoto K; Wada M; Onimaru N; Yasuda M; Amagase K; Horie S; Takeuchi K Pharmacol Res; 2012 Sep; 66(3):226-34. PubMed ID: 22699012 [TBL] [Abstract][Full Text] [Related]
15. Mediation of serotonin-induced hyperventilation via 5-HT3-receptor in European eel Anguilla anguilla. Janvier JJ; Peyraud-Waïtzenegger M; Soulier P J Comp Physiol B; 1996; 165(8):640-6. PubMed ID: 8882510 [TBL] [Abstract][Full Text] [Related]
16. Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum. Sakurai-Yamashita Y; Yamashita K; Yoshimura M; Taniyama K Life Sci; 2000; 66(1):31-4. PubMed ID: 10658921 [TBL] [Abstract][Full Text] [Related]
17. 5-HT receptor subtypes involved in the serotonin-induced inhibition of L-leucine absorption in rabbit jejunum. Salvador MT; Rodríguez-Yoldi MC; Alcalde AI; Rodríguez-Yoldi MJ Life Sci; 1997; 61(3):309-18. PubMed ID: 9217291 [TBL] [Abstract][Full Text] [Related]
18. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists. López-Rodríguez ML; Benhamú B; Viso A; Morcillo MJ; Murcia M; Orensanz L; Alfaro MJ; Martín MI Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037 [TBL] [Abstract][Full Text] [Related]
19. Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets. Minami M; Endo T; Tamakai H; Ogawa T; Hamaue N; Hirafuji M; Monma Y; Yoshioka M; Hagihara K Eur J Pharmacol; 1997 Mar; 321(3):333-42. PubMed ID: 9085045 [TBL] [Abstract][Full Text] [Related]
20. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years. Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]